Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002014822 | SCV002227621 | pathogenic | Combined oxidative phosphorylation defect type 14 | 2022-08-23 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 1-2 of the FARS2 gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FARS2 are known to be pathogenic (PMID: 22833457). A similar copy number variant has been observed in individual(s) with hereditary spastic paraplegia (PMID: 32007496). For these reasons, this variant has been classified as Pathogenic. |